Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1926.00 | 1981.25 | 0.9721 | 0.9554 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1666.00 | 1981.25 | 0.8409 | 0.7419 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1614.00 | 1981.25 | 0.8146 | 0.6984 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1411.00 | 1981.25 | 0.7122 | 0.5258 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 830.55 | 730.00 | 1981.25 | 0.3685 | -0.0978 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1160.00 | 1981.25 | 0.5855 | 0.3052 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 2074.00 | 1981.25 | 1.0468 | 1.0743 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2331.00 | 1981.25 | 1.1765 | 1.2768 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 1250.00 | 830.55 | 1620.00 | 1981.25 | 0.8177 | 0.7035 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 1250.00 | 830.55 | 856.00 | 1981.25 | 0.4321 | 0.0244 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 976.00 | 1981.25 | 0.4926 | 0.1373 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 2253.00 | 1981.25 | 1.1372 | 1.2158 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 2262.00 | 1981.25 | 1.1417 | 1.2229 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 830.55 | 1898.00 | 1981.25 | 0.9580 | 0.9327 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 830.55 | 960.00 | 1981.25 | 0.4845 | 0.1224 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 1122.00 | 1981.25 | 0.5663 | 0.2710 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 1947.00 | 1981.25 | 0.9827 | 0.9724 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 1250.00 | 830.55 | 696.00 | 1981.25 | 0.3513 | -0.1314 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2185.00 | 1981.25 | 1.1028 | 1.1623 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 1737.00 | 1981.25 | 0.8767 | 0.8008 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 830.55 | 2053.00 | 1981.25 | 1.0362 | 1.0575 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 1250.00 | 830.55 | 743.00 | 1981.25 | 0.3750 | -0.0850 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2013.00 | 1981.25 | 1.0160 | 1.0255 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4042.00 | 4027.75 | 1.0035 | 1.0064 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 3955.00 | 4027.75 | 0.9819 | 0.9675 |